Journal Information
Vol. 4. Issue 4.
Pages 387-391 (July - August 1998)
Share
Share
Download PDF
More article options
Vol. 4. Issue 4.
Pages 387-391 (July - August 1998)
ARTIGO ORIGINAL/ORIGINAL ARTICLE
Open Access
Asma, reactividade brônquica, esforço e imunoterapia
Asthma, bronchial reactivity, exercise and immunotherapy
Visits
5248
Mário Chaves Loureiro*
* Especialista em Alergologia e Pneumologia Chefe de Serviço Hospitalar
This item has received

Under a Creative Commons license
Article information
RESUMO

Muitos asmáticos. apesar da ausência de crises fortes ou queixas relevantes, após tratamento com imunoterapia específica (I.T.), mantêm pieira em esforço, mais ou menos limitante da actividade fisica. Esta questão levanta-se principalmente em indivíduos jovens, ou com profissões exigindo esforço continuado, aderindo muitas vezes deficientemente ao tratamento

Pretendeu-se avaliar, por urn lado, o comportamento da reactividade brônquica (RB), ao longo do tratamento com I.T., fora de agudizações e sem qualquer outra medicação associada, nomeadamente corticóides inalados, C.G.D.S. ou simpattcomiméticos, perante prova de esforço em tapete rolante. antes da imunoterapia, 1 ano após e entre os 24 e 36 meses de tratamento e, por outro, o grau de adesão após início da terapêutica.

Da análise dos resultados deste trabalho, não pode extrair-se haver relação directa entre a I.T. eo grau de reactividade brônquica, frente ao esforço, considerada a variabilidade da situação, no mesmo indivíduo, ao longo do tratamento. Relativamente à adesão verificaram-se 25% de abandonos nos primeiros 6 meses de tratamento e, só 5% completaram 3 anos.

REV PORTPNEUMOL 1998; IV (4): 387-391

Palavras-chave:
Asma
reactividade brônquica
esfor­ço
imunoterapia
ABSTRACT

Although abcense of crisis or relevant complaints, many asthmatic patients mantain wheezy breathing in effort with greater or minor limitation on their activity, after treatment with specific immunotherapy (S.I.T.).

This question is raised out especially among young adults and people whose job demand continuous efforts, and whose compliance is very often irresponsive.

The objective is to evaluate the behaviour of the bronchial reactivity (BR) throughout the treatement with S.I.T., without agudizations or any other associated medication such as: inhaled corticoids, C.G.D.S. or sympathomimetic drugs, with exercise testing in a treadmill, before the immunotherapy, after 1 year and between 24-36 months of the treatement, as well as, the degree of compliance after begining the S.I.T..

From the analysis of the results of this paper it is not possible to draw out any direct relation between the S.I.T. and the degree of reactivity, face to the effort, considering the variability of BR in each individual, throughout the treatement.

The compliance to S.I.T. show us 25% of losses in the first 6 months and only 5% bas completed 3 years

REV PORT PNEUMOL 1998; IV (4): 387-391

Key-words:
Asthma
bronchial reactivity
effort
immunoterapy
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
J.B. Clough, S.T. Holgate.
The natural history of bronchial hyperresponsiveness.
Clin Rev Allergy, 7 (1989), pp. 257-278
[2.]
K.F. Chung.
Role of inflammation in the hiperreacrivity of the airways in asthma.
Thorax, 41 (1986), pp. 457-462
[3.]
O.S. Postma, E.R. Bleecker, P.J. Amelung.
Genetic susceptibility to asthma-bronchial hiperresponsiveness coinherited with a major gene for atopy.
N Engl J Med, 333 (1995), pp. 894-900
[4.]
M.L. Kowalski, M. Jutel.
Mechanisms of specific immunotherapy of allergic diseases.
Allergy, 53 (1998), pp. 485-492
[5.]
I.W.B. Grant.
Does immunotherapy have a role in the treatment of asthma?.
Clin Allergy, 77 (1986), pp. 865-870
[6.]
S.R. Durham, V. Varney, M. Gaga, A.J. Frew, M. Jacobsan, A.B. Kay.
Immunotherapy and allergic inflammation.
Clin Exp Allergy, 21 (1991), pp. 206-210
[7.]
J. Bousquet, A.M. Clauzel, A. Hejjaoui, et al.
Nonspecific bronchial hypcrrcactivity in asthmatic subjects after immunotherapy with a standardized mite extract.
Am. Rev Respir Dis, 135 (1987), pp. A135
[8.]
A.B. Murray, A.C. Ferguson, B.J. Morrison.
Nonallergic bronchial hyperreactivity in asthmatic children decreases with age and increase with mite immunotherapy.
Ann Allergy, 54 (1985), pp. 541-544
[9.]
J. Bousquet, A. Hejjaoui, F.B. Michel.
Specific immunotherapy in asthma.
J Allergy Clin Immunol, 86 (1990), pp. 292-305
[10.]
J.C. Torres Dacosta, J.L. Plácido, J.P. Moreira Silva, L. Delgado, M. Vaz.
Effects of immunotherapy on symptoms, PEFR, Spirometry, and airway responsiveness in patients with allergic asthma to housedust mites (D. pteronissinus) on Inhaled steroid therapy.
Allergy, 51 (1996), pp. 238-244
[11.]
C.E. Pichler, et al.
Specific immunotherapy with Derrnatophagoides pteronissinus and D. farinae results in decreased bronchial hiperrcactivity.
Allergy, 52 (1997), pp. 274-283
[12.]
International Consensus Report on Diagnosis and Management of Asthma.
Allergy, 47 (1992),
[13.]
P.J. Sterk, L.M. Fabbrj, P.H. Quanjer, et al.
Airway rcsponsiveness:standardized challenge testing with pharmacological physical and sensitizing stimuli in adults.
Eur Respir J, 6 (1993), pp. 53-83
[14.]
S.O. Anderson.
Exercise-induced asthma.
Allergy and Allergic Diseases, pp. 692-711
[15.]
G.J.A. Cropp.
The exercise bronc hoprovocation test: standardization of procedures and evaluation of response.
J Allergy Clin Immunol, 64 (1979), pp. 627-633
[16.]
H. Folgering, P. Palange, S. Anderson.
Clinical exercise testing with reference to lung diseases: indications and protocols.
E.R.S.: European Respiratory Monograph, 2 (Dez 1997), pp. 51-83
[17.]
J. Bousquet, A. Hejjaoui, F.-B. Michel.
Specific immunotherapy in asthma.
J Allergy Clin Immunol, 86 (1990), pp. 292-305
[18.]
H.-J. Malling, B. Weeke.
Immunotherapy.
Allergy, 14 (1993), pp. 9-35
[19.]
J. Bousquet, A. Hejjaoui, A.M. Clauzel, et al.
Specific immunotherapy with a standardized Dermatophagoides pteronissinus extract. II. Prediction of efficacy of immunotherapy.
J Allergy Clin Immunol, 82 (1988), pp. 971-977
[20.]
L. Haugaard, R. Dahl, L. Jacobson.
A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects.
J Allergy Clin Immunol, 91 (1993), pp. 709-722
Copyright © 1998. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?